Loss of Nmp4 enhances bone gain from sclerostin antibody administration

Korff, C; Adaway, M; Atkinson, EG; Klunk, A; Silva, BS; Bellido, T; Plotkin, LI; Robling, AG; Bidwell, JP

Bidwell, JP (通讯作者),Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA.

BONE, 2023; 177 ():

Abstract

Severe osteoporosis is often treated with one of three Food and Drug Administration (FDA)-approved osteoanabolics. These drugs act by (1) parathyroid ......

Full Text Link